MREO - Mereo BioPharma Group plc

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 3.26

Open

$ 3.14

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.14 - $ 3.34

52 Week Range

$ 0.92 - $ 4.36

Volume

855,585

Average Volume

Market Cap

2.15B

Beta (5Y Monthly)

$ 0.97

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	03-27-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
04/29/2024 12:06:58

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
04/24/2024 20:31:44

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

Needham Reiterates Buy on Mereo BioPharma ...
04/10/2024 10:11:51

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $6 price target.

Cantor Fitzgerald Reiterates Overweight on...
03/28/2024 14:22:43

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

Needham Maintains Buy on Mereo BioPharma G...
03/28/2024 10:05:04

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and raises the price target from $5 to $6.

Mereo BioPharma Group FY EPS $(0.04) Up Fr...
03/27/2024 20:21:17

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losse...

Cantor Fitzgerald Reiterates Overweight on...
03/22/2024 17:58:44

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

Why Intel Shares Are Trading Lower By Over...
01/26/2024 18:17:28

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth q...

Booz Allen Hamilton Posts Upbeat Results, ...
01/26/2024 15:30:51

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

Mereo BioPharma Reiterates Previous Cash R...
01/08/2024 12:18:08

Mereo BioPharma Group plc (NASDAQ:MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare ...

Mereo BioPharma Reports On Recent Program ...
10/23/2023 20:04:41

Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutical company ...

why-is-mereo-biopharma-stock-trading-higher-today

Why Is Mereo BioPharma Stock Trading Highe...
10/16/2023 18:31:41

Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO) released interim data from the Phase ...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
10/16/2023 17:31:09

why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Streamline Health Solutions Shares Are...
10/16/2023 17:09:53

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Reported Earlier, Ultragenyx And Mereo Bio...
10/16/2023 06:41:11

Ultragenyx To Present Setrusumab Update At...
10/09/2023 12:04:32

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that data from its ongoing late-stage program evaluating setrusuma...

Cantor Fitzgerald Reiterates Overweight on...
09/08/2023 13:54:26

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $4 p...

Needham Reiterates Buy on Mereo BioPharma ...
09/08/2023 08:21:29

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $5 price target.